"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Descriptor ID |
D003930
|
| MeSH Number(s) |
C11.768.257 C14.907.320.382 C19.246.099.500.382
|
| Concept/Terms |
Diabetic Retinopathy- Diabetic Retinopathy
- Diabetic Retinopathies
- Retinopathies, Diabetic
- Retinopathy, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".
This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 1 | 4 |
| 2013 | 3 | 0 | 3 |
| 2014 | 5 | 1 | 6 |
| 2015 | 3 | 0 | 3 |
| 2016 | 5 | 2 | 7 |
| 2017 | 10 | 1 | 11 |
| 2018 | 6 | 2 | 8 |
| 2019 | 3 | 0 | 3 |
| 2020 | 5 | 1 | 6 |
| 2021 | 3 | 0 | 3 |
| 2022 | 2 | 0 | 2 |
| 2023 | 5 | 0 | 5 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
Phosphoinositide 3-Kinase Enhancer Protein: Insights into Its Expression and Functions in Retinal Cells. Adv Exp Med Biol. 2025; 1468:417-421.
-
Brain-Derived Neurotrophic Factor in Retinal Integrity Under Diabetic and Hypoxic Conditions. Adv Exp Med Biol. 2025; 1468:293-296.
-
Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy. Cell Metab. 2024 Jul 02; 36(7):1521-1533.e5.
-
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy. Diabetologia. 2023 09; 66(9):1705-1718.
-
The cGAS-STING pathway in diabetic retinopathy and age-related macular degeneration. Future Med Chem. 2023 Apr; 15(8):717-729.
-
Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes. Transl Vis Sci Technol. 2023 04 03; 12(4):20.
-
Diabetes Retinopathy: New Ways to Detect and Treat. Methods Mol Biol. 2023; 2592:89-100.
-
Untargeted Analysis of Lipids Containing Very Long Chain Fatty Acids in Retina and Retinal Tight Junctions. Methods Mol Biol. 2023; 2625:269-290.
-
Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). BMJ Open Ophthalmol. 2022 12; 7(1).
-
ASSESSMENT OF FLUORESCEIN ANGIOGRAPHY NONPERFUSION IN EYES WITH DIABETIC RETINOPATHY USING ULTRAWIDE FIELD RETINAL IMAGING. Retina. 2022 07 01; 42(7):1302-1310.